This week, eight of the biggest drug companies announced raking in $98.2 billion in revenue in the first quarter of this year. Also during the first few months of 2024, these companies distributed $15.1 billion to shareholders through stock buybacks and dividends. They make billions while charging Americans prices up to four times higher than in other countries, forcing patients to cut pills and s...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
